Jerash (JRSH) Q4 2026 Earnings Transcript

Jerash Holdings reported Q4 revenue of $42.9 million, up 46.6% year over year, with operating income surging to $2.3 million from $434,000 and net income rising to $1.7 million, or $0.12 per diluted share. Management said facilities are fully booked through December 2026, but full-year FY27 growth is constrained by capacity; Q1 FY27 revenue is guided to rise 20%-22% with gross margin of 15%-17%. The company also maintained a quarterly dividend of $0.05 per share and said tariff impacts have not been material, though Middle East conditions remain a risk to additional orders.

Analysis

This is a capacity-constrained compounding story, not a cyclical demand story. The critical second-order effect is that management is now effectively selling future utilization before it is built, which should keep reported growth resilient for the next 2-3 quarters but also caps upside until the first renovation phase is online. That makes the near-term earnings path look better than the medium-term elasticity of the model: revenue can accelerate only as fast as machines, labor, and logistics slots are added.

The market is likely underestimating how much operating leverage can still come through even if gross margin does not expand materially. With SG&A already running far below revenue growth, incremental volume should continue to fall disproportionately to the bottom line, especially if the new customer mix stays concentrated in simpler styles with scale economics. The more important margin risk is not tariffs, which appear pass-through, but execution during the capacity build-out: any slip in line conversion or worker ramp would hit shipments before it hits headline demand.

Geopolitics is the hidden swing factor. A meaningful portion of incremental demand is conditional on regional stability, so this is a months-long catalyst stack rather than a one-quarter event; the setup works until it doesn’t, and then it can break quickly if buyers re-route orders away from Jordan. The contrarian point is that the stock may still be cheap if investors are anchoring on low-margin CM manufacturing and missing the fact that supply scarcity plus customer concentration can support unusually durable pricing discipline during the build-out period.

Key Decisions for Investors

• Long JRSH on a 3-6 month horizon ahead of the first capacity expansion milestone; thesis is continued operating leverage before the market fully prices the booked-through-2026 backlog. Tight risk control: exit if order-book confirmations start slipping below the historical near-certainty conversion rate.
• Use call spreads rather than outright stock if liquidity allows: buy 6-9 month JRSH calls and finance with higher-strike calls, targeting a re-rating on visible capacity growth while limiting downside if Middle East demand pauses.
• Pair trade: long JRSH / short a broad apparel manufacturing peer basket with less booked capacity and weaker operating leverage. The relative trade should work if investors reward certainty of utilization over generic industry exposure.
• Do not chase after the next headline order announcement; wait for evidence that the first 15% capacity expansion is translating into shipped volume, not just booked demand. The inflection point matters more than the backlog.